Neeraj Arora

Dr. Neeraj Arora


Research Focus & Metrics

Representative Publications

View All Publications
9 January 2025 in Journal of Marketing
Verified
Journal Article
Closed access
NANeeraj Arora
Neeraj Arora
ICIshita Chakraborty
Ishita Chakraborty
YNYohei Nishimura
Yohei Nishimura
The authors’ central premise is that a human–LLM (large language model) hybrid approach leads to efficiency and effectiveness gains in the marketing research process. In qualitative research, they show that LLMs can assist in both data generation and analysis; LLMs effectively create sample characteristics, generate synthetic respondents, and conduct and moderate in-depth interviews. The AI–human hybrid generates information-rich, coherent data that surpasses human-only data in depth and insightfulness and matches human performance in data analysis tasks of generating themes and summaries. Evidence from expert judges shows that humans and LLMs possess complementary skills; the human–LLM hybrid outperforms its human-only or LLM-only counterpart. For quantitative research, the LLM correctly picks the answer direction and valence, with the quality of synthetic data significantly improving through few-shot learning and retrieval-augmented generation. The authors demonstrate the value of the AI–human hybrid by collaborating with a Fortune 500 food company and replicating a 2019 qualitative and quantitative study using GPT-4. For their empirical investigation, the authors design the system architecture and prompts to create personas, ask questions, and obtain responses from synthetic respondents. They provide road maps for integrating LLMs into qualitative and quantitative marketing research and conclude that LLMs serve as valuable collaborators in the insight generation process.

1 October 2012 in Leukemia & Lymphoma
Verified
Journal Article
Closed access
NANeeraj Arora
Neeraj Arora
MMMarie Therese Manipadam
Marie Therese Manipadam
SNSheila Nair
Sheila Nair
This study aimed to analyze the distribution of lymphoid neoplasms in a single tertiary care center in India using the World Health Organization (WHO) 2008 classification. Histological material of 5115 patients with histopathological diagnosis of lymphoma, diagnosed over a period of 10 years (2001–2010), was analyzed retrospectively. Hodgkin lymphoma (HL) constituted 21.3% (n = 1089) and non-Hodgkin lymphomas (NHLs) constituted 78.7% (n = 4026). Of these, B-cell neoplasms accounted for 78.6% (n = 3166) and T-cell/natural killer (NK)-cell neoplasms 20.2% (n = 815) of the NHLs. The commonest subtype of NHL was diffuse large B-cell lymphoma (n = 1886, 46.9%). The frequency of peripheral T-cell/NK-cell lymphomas in this study was higher than in the Western literature but less than the frequency documented in some Asian countries. Similar to the Western literature but in contrast to previous Indian studies, peripheral T-cell lymphoma, not otherwise specified (PTCL NOS) (n = 238) was the commonest histological subtype of T-cell/NK-cell NHL in this study and constituted 5.9% of the total NHLs. Mixed cellularity (MC-CHL) (n = 488, 45%) was the major subtype of HL. Primary extranodal lymphoma (ENL) accounted for 32.8% (n = 1321) of all NHLs and most frequently involved the gastrointestinal tract. This study also documents the frequency of many rare types of lymphoma in South India.

1 January 2011 in Indian Journal of Pathology and Microbiology
Verified
Journal Article
Open access
NANeeraj Arora
Neeraj Arora
MMMarieTherese Manipadam
MarieTherese Manipadam
APAnna Pulimood
Anna Pulimood
BRBalakrishnan Ramakrishna
Balakrishnan Ramakrishna
ACAshok Chacko
Ashok Chacko
SNSheila Nair
Sheila Nair
Ogical subtypes and sites of involvement. This study was undertaken to ascertain the anatomic distribution, histological subtypes and sites of all GIT lymphomas presenting to a tertiary referral hospital in southern India. Materials and Methods: The histological material of 361 patients over a period of 10 years (2001-2010), with histopathological diagnosis of lymphoma involving the GIT (both primary and secondary), was analyzed retrospectively. All lymphomas were reclassified according to the World Health Organization 2008 classification. Results: These 361 cases include 336 primary and 25 cases of lymphomas, where the involvement was secondary. Primary lymphomas consisted of 267 males (79.64%) and 68 females (20.24%) with a male:female ratio of 3.93:1. The mean age was 45 years (range 3-88). Diffuse large B-cell lymphoma (DLBCL) was the commonest subtype (222 cases; 66.71%), followed by low-grade marginal zone lymphoma of the mucosa associated lymphoid tissue (MALT) type (34 cases; 10.12%) and Burkitt's lymphoma (35 cases; 10.48%). The commonest site was stomach (180 cases; 53.57%), followed by small intestine (79 cases; 23.51%) and large intestine (68 cases; 20.23%), respectively. There were some uncommon types of GIT lymphomas documented during the study. Conclusion: In this largest retrospective single centre study from India, we establish that the pattern of distribution of primary GIT lymphomas (PGLs) in India is similar to the western literature in that the stomach is the commonest site of PGL and DLBCL is the commonest histological subtype. Immunoproliferative small intestinal disease cases were seen in this study, which is uncommon in the west....

4 February 2019 in Cytometry Part B: Clinical Cytometry
Verified
Journal Article
Closed access
PDF file
NGNishit Gupta
Nishit Gupta
MPMayur Parihar
Mayur Parihar
SBSambhunath Banerjee
Sambhunath Banerjee
SBSubhajit Brahma
Subhajit Brahma
RPRavikiran Pawar
Ravikiran Pawar
NANeeraj Arora
Neeraj Arora

1 January 2017 in Indian Journal of Pathology and Microbiology
Verified
Journal Article
Open access
NANeeraj Arora
Neeraj Arora
RPRavikiranN Pawar
RavikiranN Pawar
SBSambhunath Banerjee
Sambhunath Banerjee
SBSubhajit Bramha
Subhajit Bramha
SKShekhar Krishnan
Shekhar Krishnan
DMDk Mishra
Dk Mishra
By the presence of dual population of blasts belonging to two or more lineages. We highlight the clinicopathological, immunophenotype, and genetic data of a cohort (n = 14) of patients diagnosed and treated at our center. Materials and Methods: We retrospectively analyzed consecutive cases of MPAL diagnosed in our flow cytometry laboratory from May 2012 to August 2015. These cases were diagnosed based on immunophenotyping of peripheral blood/bone marrow aspirates and morphology/genetics wherever available as per the World Health Organization (WHO) 2008 guideline. Results: Among 628 consecutive acute leukemia (AL) cases diagnosed and evaluated during this period, we identified 14 (2.2%) patients with MPAL fulfilling WHO 2008/EGIL criteria for immunological characterizing of AL criteria. Majority of these were males (n = 8, male:female ratio 1.3:1) and adults (n = 11, 78.5%). The median age of this cohort was 41 years (range 2–80). These cases were further classified as: B/myeloid (n = 9), T/myeloid (n = 4), and B/T MPAL (n = 1). Cytogenetics was available in 12 out of 14 cases, out of which, three cases had normal karyotype, three with t(9;22)(q34;q11), and two cases with complex karyotype. We also came across a rare case of B + T lymphoid MPAL who had mixed-lineage leukemia gene t(v; 11q23) rearrangement. Conclusion: MPAL is a complex entity with heterogeneous clinical, immunophenotypic, cytogenetic, and molecular features. Multiparametric flowcytometry by using comprehensive antibody panels is a valuable tool for diagnosis. Subsequent cytogenetic and molecular analysis for further prognostic stratification and treatment modalities are important....

29 February 2024 in Journal of Pediatric Hematology/Oncology
Verified
Journal Article
Closed access
SCSpandan Chaudhary
Spandan Chaudhary
PCPooja Msc Chaudhary
Pooja Msc Chaudhary
FAFiroz Msc Ahmad
Firoz Msc Ahmad
NANeeraj Arora
Neeraj Arora
Acute myeloid leukemia (AML) is a genetically heterogeneous clonal disorder characterized by the accumulation of acquired somatic genetic alterations in hematopoietic progenitor cells, which alter the normal mechanisms of self-renewal, proliferation, and differentiation. Due to significant technological advancements in sequencing technologies in the last 2 decades, classification and prognostic scoring of AML has been refined, and multiple guidelines are now available for the same. The authors have tried to summarize, latest guidelines for AML diagnosis, important markers associated, epigenetics markers, various AML fusions and their importance, etc. Review of literature suggests lack of study or comprehensive information about current NGS panels for AML diagnosis, genes and fusions covered, their technical know-how, etc. To solve this issue, the authors have tried to present detailed review about currently in use next-generation sequencing myeloid panels and their offerings.